• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzonitriles

Recent Advances in the Study of 3-Bromo-4-isopropoxy-5-methoxybenzonitrile (CAS: 515848-62-1) in Chemical Biology and Pharmaceutical Research

The compound 3-Bromo-4-isopropoxy-5-methoxybenzonitrile (CAS: 515848-62-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This aromatic nitrile derivative, characterized by its unique substitution pattern, has shown promising potential as a versatile intermediate in the synthesis of bioactive molecules. Recent studies have explored its applications in drug discovery, particularly in the development of kinase inhibitors and other targeted therapies.

One of the key areas of interest is the role of 3-Bromo-4-isopropoxy-5-methoxybenzonitrile in the synthesis of small-molecule inhibitors targeting protein kinases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility as a building block for the development of selective inhibitors of the MAPK pathway, which is implicated in various cancers. The bromo and isopropoxy substituents were found to enhance binding affinity to the ATP-binding pocket of kinases, while the nitrile group contributed to improved metabolic stability.

In addition to its pharmacological applications, recent research has also investigated the compound's physicochemical properties. A computational study published in ACS Omega in 2024 employed density functional theory (DFT) calculations to analyze its electronic structure and reactivity. The results indicated that the electron-withdrawing nitrile group significantly influences the compound's reactivity in nucleophilic aromatic substitution reactions, making it a valuable scaffold for further chemical modifications.

Another notable development is the use of 3-Bromo-4-isopropoxy-5-methoxybenzonitrile in the synthesis of fluorescent probes for cellular imaging. A 2023 paper in Chemical Communications reported its incorporation into a novel probe for detecting reactive oxygen species (ROS) in live cells. The probe exhibited high selectivity and sensitivity, attributed to the unique electronic properties imparted by the compound's substitution pattern.

Despite these advancements, challenges remain in optimizing the synthetic routes for 3-Bromo-4-isopropoxy-5-methoxybenzonitrile. Recent efforts have focused on developing more efficient and scalable methods, as highlighted in a 2024 Organic Process Research & Development article. The study proposed a streamlined two-step synthesis from commercially available starting materials, achieving a 75% overall yield and reducing the need for hazardous reagents.

In conclusion, 3-Bromo-4-isopropoxy-5-methoxybenzonitrile (CAS: 515848-62-1) continues to emerge as a valuable tool in chemical biology and drug discovery. Its unique structural features and versatile reactivity make it a promising candidate for further exploration in targeted therapy development and diagnostic applications. Future research directions may include expanding its utility in fragment-based drug design and exploring its potential in other therapeutic areas beyond oncology.

• 330462-57-2(3-Bromo-5-ethoxy-4-hydroxybenzonitrile)
• 495396-35-5(3-Bromo-4-ethoxy-5-methoxybenzonitrile)
• 515848-04-1(3-Bromo-5-methoxy-4-propoxybenzonitrile)
• 781654-31-7(3-Bromo-4,5-dimethoxybenzonitrile)
• 52805-45-5(3-Bromo-4-hydroxy-5-methoxybenzonitrile)
• 515831-52-4(3-Bromo-5-ethoxy-4-methoxybenzonitrile)
• 515847-71-9(2-Bromo-4-cyano-6-methoxyphenyl Acetate)
• 93840-60-9(1,3-Bis(2’bromo-4’-cyano-phenoxy)propane)
• 514856-13-4(3-Bromo-4,5-diethoxybenzonitrile)
• 515846-11-4(2-Bromo-4-isopropoxy-5-methoxybenzonitrile)